BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fujiwara-Tani R, Fujii K, Mori S, Kishi S, Sasaki T, Ohmori H, Nakashima C, Kawahara I, Nishiguchi Y, Mori T, Sho M, Kondoh M, Luo Y, Kuniyasu H. Role of Clostridium perfringens Enterotoxin on YAP Activation in Colonic Sessile Serrated Adenoma/ Polyps with Dysplasia. Int J Mol Sci 2020;21:E3840. [PMID: 32481659 DOI: 10.3390/ijms21113840] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Artemaki PI, Kontos CK. Editorial for the Special Issue "Molecular Biomarkers in Colorectal Adenocarcinoma". Int J Mol Sci 2021;22:2052. [PMID: 33669582 DOI: 10.3390/ijms22042052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Li J. Context-Dependent Roles of Claudins in Tumorigenesis. Front Oncol 2021;11:676781. [PMID: 34354941 DOI: 10.3389/fonc.2021.676781] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Owari T, Sasaki T, Fujii K, Fujiwara-Tani R, Kishi S, Mori S, Mori T, Goto K, Kawahara I, Nakai Y, Miyake M, Luo Y, Tanaka N, Kondoh M, Fujimoto K, Kuniyasu H. Role of Nuclear Claudin-4 in Renal Cell Carcinoma. Int J Mol Sci 2020;21:E8340. [PMID: 33172177 DOI: 10.3390/ijms21218340] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 DeDecker L, Coppedge B, Avelar-Barragan J, Karnes W, Whiteson K. Microbiome distinctions between the CRC carcinogenic pathways. Gut Microbes 2021;13:1854641. [PMID: 33446008 DOI: 10.1080/19490976.2020.1854641] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
5 Maesaka F, Kuwada M, Horii S, Kishi S, Fujiwara-Tani R, Mori S, Fujii K, Mori T, Ohmori H, Owari T, Miyake M, Nakai Y, Tanaka N, Bhawal UK, Luo Y, Kondoh M, Fujimoto K, Kuniyasu H. Hypomethylation of CLDN4 Gene Promoter Is Associated with Malignant Phenotype in Urinary Bladder Cancer. Int J Mol Sci 2022;23:6516. [PMID: 35742959 DOI: 10.3390/ijms23126516] [Reference Citation Analysis]
6 Li J. Targeting claudins in cancer: diagnosis, prognosis and therapy. Am J Cancer Res 2021;11:3406-24. [PMID: 34354852] [Reference Citation Analysis]